These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 19782031)

  • 1. Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.
    Cai Z; Chehab NH; Pavletich NP
    Mol Cell; 2009 Sep; 35(6):818-29. PubMed ID: 19782031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the intramolecular phosphorylation sites in human Chk2.
    Olsen BB; Larsen MR; Boldyreff B; Niefind K; Issinger OG
    Mutat Res; 2008 Nov; 646(1-2):50-9. PubMed ID: 18812180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the Chk2 protein kinase by oligomerization-mediated cis- and trans-phosphorylation.
    Schwarz JK; Lovly CM; Piwnica-Worms H
    Mol Cancer Res; 2003 Jun; 1(8):598-609. PubMed ID: 12805407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.
    Oliver AW; Paul A; Boxall KJ; Barrie SE; Aherne GW; Garrett MD; Mittnacht S; Pearl LH
    EMBO J; 2006 Jul; 25(13):3179-90. PubMed ID: 16794575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways.
    Lou Z; Minter-Dykhouse K; Wu X; Chen J
    Nature; 2003 Feb; 421(6926):957-61. PubMed ID: 12607004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dimeric kinase assembly underlying autophosphorylation in the p21 activated kinases.
    Pirruccello M; Sondermann H; Pelton JG; Pellicena P; Hoelz A; Chernoff J; Wemmer DE; Kuriyan J
    J Mol Biol; 2006 Aug; 361(2):312-26. PubMed ID: 16837009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation segment exchange: a common mechanism of kinase autophosphorylation?
    Oliver AW; Knapp S; Pearl LH
    Trends Biochem Sci; 2007 Aug; 32(8):351-6. PubMed ID: 17627826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk2 oligomerization studied by phosphopeptide ligation: implications for regulation and phosphodependent interactions.
    Li J; Taylor IA; Lloyd J; Clapperton JA; Howell S; MacMillan D; Smerdon SJ
    J Biol Chem; 2008 Dec; 283(51):36019-30. PubMed ID: 18948271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Chk2 protein kinase.
    Ahn J; Urist M; Prives C
    DNA Repair (Amst); 2004; 3(8-9):1039-47. PubMed ID: 15279791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophosphorylated residues involved in the regulation of human chk2 in vitro.
    Gabant G; Lorphelin A; Nozerand N; Marchetti C; Bellanger L; Dedieu A; Quéméneur E; Alpha-Bazin B
    J Mol Biol; 2008 Jul; 380(3):489-503. PubMed ID: 18538787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells.
    Zhang P; Gao W; Li H; Reed E; Chen F
    Biochem Biophys Res Commun; 2005 Mar; 328(2):567-72. PubMed ID: 15694385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural delineation of MDC1-FHA domain binding with CHK2-pThr68.
    Wu HH; Wu PY; Huang KF; Kao YY; Tsai MD
    Biochemistry; 2012 Jan; 51(2):575-7. PubMed ID: 22211259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation.
    Wei F; Xie Y; Tao L; Tang D
    Cell Signal; 2010 Nov; 22(11):1783-9. PubMed ID: 20637859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chk2 activation and phosphorylation-dependent oligomerization.
    Xu X; Tsvetkov LM; Stern DF
    Mol Cell Biol; 2002 Jun; 22(12):4419-32. PubMed ID: 12024051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
    Miyasaka Y; Nagai E; Yamaguchi H; Fujii K; Inoue T; Ohuchida K; Yamada T; Mizumoto K; Tanaka M; Tsuneyoshi M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4371-7. PubMed ID: 17671118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ATM-dependent DNA damage signaling pathway.
    Kitagawa R; Kastan MB
    Cold Spring Harb Symp Quant Biol; 2005; 70():99-109. PubMed ID: 16869743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.